EDUARDO PINAR BERMUDEZ

de la Torre Hernández JM, Rumoroso JR, Ojeda S, Brugaletta S, Cascón JD, Ruisánchez C, Sánchez Gila J, Roa J, Tizón H, Gutiérrez H, Larman M, García Camarero T, Pinar E, Díaz JF, Pan M, Morillas Bueno M, Oyonarte JM, Ruiz Guerrero L, Ble M, Rubio Patón R, Arnold R, Echegaray K, de la Morena G, Sabate M. Angina and Ischemia at 2 Years With Bioresorbable Vascular Scaffolds and Metallic Drug-eluting Stents. ESTROFA Ischemia BVS-mDES Study. Rev Esp Cardiol (Engl Ed). 2018 May;71(5):327-334. doi: 10.1016/j.rec.2017.03.024. Epub 2017 Apr 29. English, Spanish. PubMed PMID: 28461150.

AÑO: 2018; IF: 5.126

28461150

García-Lara J, García-Puente J, Mateo-Martínez A, Pinar-Bermúdez E, Gutiérrez-García F, Valdés-Chávarri M. Percutaneous Treatment of Early Denegeration of a Sutureless Bioprosthesis. Rev Esp Cardiol (Engl Ed). 2018 May;71(5):398-399. doi: 10.1016/j.rec.2017.05.023. Epub 2017 Jun 17. English, Spanish. PubMed PMID: 28629948.

AÑO: 2018

28629948

Brugaletta S, Gori T, Low AF, Tousek P, Pinar E, Gomez-Lara J, Ortega-Paz L, Schulz E, Chan MY, Kocka V, Hurtado J, Gomez-Hospital JA, Giacchi G, Münzel T, Lee CH, Cequier A, Valdés M, Widimsky P, Serruys PW, Sabaté M. ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison. Int J Cardiol. 2016 Jul 1;214:483-4. doi: 10.1016/j.ijcard.2016.04.016. Epub 2016 Apr 7. PubMed PMID: 27096965.

AÑO: 2016; IF: 6.189

27096965

Brugaletta S, Gori T, Low AF, Tousek P, Pinar E, Gomez-Lara J, Scalone G, Schulz E, Chan MY, Kocka V, Hurtado J, Gomez-Hospital JA, Münzel T, Lee CH, Cequier A, Valdés M, Widimsky P, Serruys PW, Sabaté M. Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction). JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):189-97. doi: 10.1016/j.jcin.2014.10.005. Erratum in: JACC Cardiovasc Interv. 2015 Mar;8(3):503. PubMed PMID: 25616924.

AÑO: 2015; IF: 7.63

25616924

Gómez-Hospital JA, Mauri J, Pinar E, Goicolea J, García Del Blanco B, Serra A, Tizon-Marcos H, Molina E, Sanchez E, Aragón V, Masotti M, Rodríguez J, Jiménez J, Ortas R, Martínez P, Serra B, Moreu J, Diego Nieto G, Bossa F, Nogales JM, Bassaganyas J, Díaz J, Cascón JD. The TITAN-AMI multicenter registry evaluating the usage of Titan2 stent in patients with ST segment elevation myocardial infarction. Final result at 12-month follow-up. Minerva Cardioangiol. 2015 Feb;63(1):11-20. PubMed PMID: 25600779.

AÑO: 2015; IF: 0.752

25600779